Search filters

Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on November 2007
Author/s

author: Fortunato Ciardiello  Teresa Troiani 

Publication date November 1, 2007
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item